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The apicomplexan Babesia microti is the primary causative agent of human babesiosis,
one of the most broadly distributed tick-borne diseases worldwide. B. microti undergoes
a complex lifecycle within both the mammalian host and the tick vector, and employs
several different specific molecular mechanisms to enter host cells. Enolase, the key
glycolytic enzyme in intracellular glucose metabolism, can also be expressed on the
parasite’s outer surface, binds to human plasminogen, and coordinates apicomplexan
parasite invasion of host cells, however, it lacks sorting sequences or lipoprotein
anchor sites. In the present study, we isolated the coding gene of B. microti enolase
(BmEno), expressed it within E. coli and purified the recombinant BmEno protein
(rBmEno). Consequently, we confirmed cytoplasmic and surface localization of BmEno
via immunofluorescence, and demonstrated that rBmEno catalyzes the dehydration
of 2-phospho-D-glycerate to phosphoenolpyruvate. Moreover, our results showed that
rBmEno binds to human plasminogen, and that the lysine analog ε-aminocaproic acid
significantly inhibited this binding. Furthermore plasminogen bound to rBmEno converts
to active plasmin. Additionally, actively immunizing mice with rBmEno could evoke a
partial protective immunity against B. microti infection following challenge. In conclusion,
B. microti enolase is a multifunctional cytoplasmic protein which is also expressed at
the parasitic outer surface, facilitates binding to host plasminogen, and could partially
protect hosts against parasite infection.
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INTRODUCTION
Human babesiosis, caused by the intraerythrocytic apicomplexan parasite babesia, is an emerging
infectious disease which manifests worldwide, including the Americas, Europe, Africa, and Asia
(Vannier and Krause, 2012). Humans are most commonly infected via bites from ixodid ticks,
the predominant Babesia vector; however, blood transfusions and trans-placental transmission can
also play important roles in the infection process (Vannier and Krause, 2012). Following infection,
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the patient usually presents as asymptomatic or with non-specific
symptoms such as fever, often in conjunction with fatigue,
chills, sweats, headache, myalgia, arthralgia, and/or anorexia,
which may include thrombocytopenia, hemolytic anemia, and/or
elevated liver enzyme levels (Sanchez et al., 2016).
Babesia is one of the most important tick-borne pathogens
in terms of public health, and has a complex lifecycle with
developmental stages occurring both within the mammalian
host and the tick vector (Vannier and Krause, 2012). As one
of its critical developmental steps initially takes place within
mammalian host red blood cells (RBCs), the parasite has
developed specialized methods to enter RBCs (Lobo et al.,
2012). Similar to other apicomplexan parasites, Babesia invades
RBCs via the coordinated secretion of several molecules
including micronemes, rhoptries, and dense granules from
their specialized secretory organelles (Tyler et al., 2011; Lobo
et al., 2012). Babesia then completes its life cycle within
tick vectors to enable effective transmission. The parasite
migrates across the tick gut barrier into the hemolymph
via unknown mechanisms, and then into the tick salivary
glands (Liu and Bonnet, 2014). Several tick-expressed molecules
have been identified which protect the tick against Babesia
invasion in the gut epithelium (Tsuji et al., 2007, 2008),
however, to the best of our knowledge, no Babesia molecules
orchestrating tick gut epithelium invasion have been identified,
until now.
A number of vector-borne pathogens express special proteins,
such as enolase, on their cell surface to coordinate vector
invasion (Pal et al., 2004; Ghosh et al., 2011; Toledo et al.,
2012). Enolase is the key glycolytic enzyme in intracellular
glucose metabolism, and catalyzes the reversible dehydration
of 2-phospho-D-glycerate (2-PGA) to phosphoenolpyruvate
(PEP) in the penultimate step of glycolysis (Pancholi, 2001;
Diaz-Ramos et al., 2012). Moreover, enolase has been reported
to be expressed on the surface of a variety of eukaryotic cells,
even though it lacks trans-membrane domains or signal peptides
(Pancholi, 2001; Diaz-Ramos et al., 2012). Surface expressed
enolase has been identified as a plasminogen receptor, which
can be subsequently converted into active plasmin, a strong
serine protease facilitating the host invasion process (Pancholi,
2001; Ghosh and Jacobs-Lorena, 2011; Diaz-Ramos et al., 2012).
In recent years, a variety of pathogenic parasites have also
been found to express enolase on their surface, and it is thus
thought to aid with host invasion (Figueiredo et al., 2015; Alves
et al., 2016; Mahana et al., 2016). Remarkably, enolase has also
been identified on the surface of vector-borne pathogens (e.g.,
Plasmodium falciparum and Borrelia burgdorferi), and plays an
important role during pathogen invasion of vector gut by binding
mammalian plasminogen (Ghosh et al., 2011; Toledo et al.,
2012).
Enolase has also been suggested to be a major immunogenic
protein with antigenic properties, and could therefore be a
suitable candidate vaccine for pathogen infection (Zhang et al.,
2015; Mahana et al., 2016; Membrebe et al., 2016). Recently,
enolase has been demonstrated satisfactory protective properties
against Plasmodium spp. challenge, suggesting that the protein
could act as a viable vaccine for malaria (Pal-Bhowmick et al.,
2007; Zhang et al., 2016). As both diseases are blood-borne
apicomplexan parasites, Plasmodium spp. and Babesia spp.
express a variety of similar functional proteins, such as rhoptry-
associated protein 1, and apical membrane antigen 1 (Brown
et al., 1996; Jakobsen et al., 1996; Xu et al., 2000; Tonkin et al.,
2013), which are then targeted by the host to mount immune
responses and protect against parasitic infection. One of the
Babesia genus, Babesia microti, is the primary causative agent of
human babesiosis in many regions worldwide. According to the
published genomic sequences of B. microti, a single enolase gene
located on chromosome III has been identified (Cornillot et al.,
2012). However, the function of the expressed protein has not
been confirmed, and its role during parasite infection processes
is not yet clear.
In this study, we report the cloning, recombinant expression,
biological characteristics, and potentially protective properties
of B. microti enolase (BmEno). We demonstrate that the
surface expressed BmEno catalyzes 2-PGA dehydration to
PEP, and likewise also contributes to human plasminogen
activation. Additionally, recombinant BmEno demonstrated a
partial protective role against B. microti infection. However,
further research is needed in order to evaluate BmEno’s potential
as a candidate vaccine to control babesiosis infection.
MATERIALS AND METHODS
Ethics Statements
This study was carried out in strict accordance with the
recommendations of the guidelines for the Care and Use of
Laboratory Animals of the Laboratory Animal Ethics Committee
of Xuzhou Medical University. The protocol was approved by
the Laboratory Animal Ethics Committee of Xuzhou Medical
University (Permit Number: 201547).
Parasites and Animals
The B. microti strain (ATCC R© PRA-99TM) was provided by
the National Institute of Parasitic Diseases, Chinese Center
for Disease Control and Prevention (Shanghai, China),
and maintained in our laboratory. The NOD-SCID (non-
obese diabetic/severe combined immunodeficiency) mice
were used as reservoirs for preserving the parasites and the
percentage of parasitized RBCs was determined via Giemsa-
stained thin blood films. Female Balb/c mice (4–6 weeks
old) were intraperitoneally inoculated with 100 µl infected
blood, which was collected, heparinized, and diluted with
sterile saline to achieve a 30% RBC parasitic infection rate.
Parasites were isolated once 50–60% of RBCs were infected.
All mice were purchased from NBRI (Nanjing Biomedical
Research Institute of Nanjing University, Nanjing, China)
and maintained at the Animal Center of Xuzhou Medical
University.
Reagents
All reagents were purchased from Sigma–Aldrich (St. Louis, MO,
USA) unless otherwise specified.
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Bioinformatics Analysis of the BmEno
Gene and Predicted Protein
Babesia microti enolase nucleotide sequence BLAST searches
against published genomic sequences of B. microti were
performed with the NCBI nucleotide database search program
(Cornillot et al., 2012). The enolase signature sequence and other
domains were defined using the ScanProsite online software1, and
the MotifScan online software2. Multiple-sequence alignments
were built with the ClustalX program3.
BmEno Cloning, Recombinant
Expression, and Purification
Total RNA was isolated from B. microti-infected RBCs with
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. The gene fragment encoding
the entire BmEno coding sequence was obtained using RT-PCR
amplified with a One Step PrimeScript RT-PCR Kit (Takara,
Dalian, China), and the primers: BmEnoF (5′-CAGGGATCC
ATGACAAAGATAATTAGCGC-3′) and BmEnoR (5′-CCGCTC
GAGTTACTTGTTAAAAACTTTGC-3′). Primers contained
BamHI and XhoI restriction sites (underlined) to assist
subsequent cloning into the expression vector pGEX-4T-2
(TransGen Biotech, Beijing, China), containing a GST tag to
facilitate purification. The resulting plasmid was transformed
into Escherichia coli BL21 Star (DE3) competent cells.
For recombinant expression, E. coli cells were grown
to 0.5 OD600 at 37◦C, and then induced overnight with
0.4 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 25◦C.
Cell cultures were harvested by centrifugation and the resulting
cell pellet was resuspended in sonication buffer (1 × PBS, 0.1%
TritonX-100, 1 mg/mL lysosome, 5 mM DTT, 0.5 mM PMSF, pH
7.4) and lysed on ice with a sonicator. Debris was then pelleted
by centrifugation, and the supernatant (containing recombinant
BmEno, rBmEno) was purified by an affinity chromatography
system on a GSTrap 4B column following the manufacturer’s
instructions (GE Healthcare, Pittsburgh, PA, USA). Thrombin
was used to cut the GST tag from the purified protein, which
was then analyzed by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS–PAGE) followed by Coomassie brilliant
blue staining. The purified protein was quantitated, divided into
aliquots, and stored at−80◦C until used.
Western Blot Analysis
To determine whether anti-B. microti antibody recognizes
rBmEno, Western blot was performed. In brief, 2 µg of purified
rBmEno were separated by SDS–PAGE, and then transferred
to activated polyvinylidene difluoride (PVDF) membrane.
Membranes were blocked with Tris-buffered saline-Tween 20
(TBST; 20 mM Tris-base, 150 mM NaCl, 0.05% (v/v) Tween 20,
pH 7.5) containing 5% (w/v) dry non-fat milk powder for 3 h
at room temperature. The membrane was then either incubated
with mouse anti-B. microti serum or normal mouse serum (1:500
1http://prosite.expasy.org/scanprosite/
2http://myhits.isb-sib.ch/cgi-bin/motif_scan
3http://www.ebi.ac.uk/Tools/msa/clustalo/
dilution) overnight at 4◦C. Following three washes in TBST,
the membrane was incubated with enhanced chemiluminescence
(ECL)-goat alkaline phosphatase (AP)-conjugated anti-mouse
IgG (1:2000 dilution) for 2 h at room temperature. Following
additional washings, the membrane was stained with ECL
substrate solution and reactions were detected by exposure to
X-ray film.
Generation of Mouse Antisera against
rBmEno
To generate polyclonal antibodies against rBmEno, five female
Balb/c mice (4–6 weeks old) were immunized three times at
two-weekly intervals by subcutaneous injection with purified
rBmEno protein (50 µg/mouse), mixed with MONTANIDETM
ISA 70 VG adjuvant (Seppic, Puteaux, France). One week after
the last immunization, mouse blood samples were isolated
to generate anti-serum by centrifuging. Antibody titer was
measured using an indirect enzyme-linked immunosorbent assay
(ELISA), where each well of a 96-well plate was coated with
2 µg rBmEno diluted in 100 µl coating buffer (1.5 g/L Na2CO3,
2.93 g/L NaHCO3, pH 9.6). Serum aliquots were then stored at
−20◦C until use.
Immunoprecipitation
To determine whether anti-rBmEno antibody recognizes native
BmEno, immunoprecipitation was performed. Briefly, 2 mg of
B. microti-infected or normal mouse RBC lysates were mixed
with 10 µl anti-rBmEno antibody overnight at 4◦C. Then 30 µl
of a 1:2 A/G-Sepharose protein slurry was added for 2 h at
4◦C. After three washes with PBS, the precipitate was mixed
with SDS–PAGE sample buffer and boiled. Western blot was
performed as described above.
Indirect Immunofluorescence Assay
Babesia microti-infected RBCs were smeared on coverslips, and
fixed with 100% methanol for 30 min at −20◦C. Samples were
then permeabilized with PBS containing 0.1% (v/v) Triton X-100
for 15 min at room temperature. Following three washes with
PBS, the samples were blocked in BSA-PBS containing 5%
(w/v) BSA for 30 min at room temperature. Samples were then
incubated overnight with polyclonal mouse anti-rBmEno serum
(1:20 dilution) at room temperature. After three washes, samples
were incubated with FITC-conjugated goat anti-mouse IgG (1:50
dilution) for 1 h at room temperature. After three washes,
coverslips were briefly swirled in distilled water, mounted with
6-diamidino-2-phenylindole (DAPI), and then sealed with nail
polish. Finally, images were acquired and analyzed using a ZEISS
LSM 880 confocal microscope system (Zeiss, Munich, Germany).
Characterization of rBmEno Enzymatic
Activity
The enzymatic activity of purified rBmEno was determined
by direct monitoring of absorbance enhancement at 240 nm
and 30◦C using a Synergy HT spectrophotometer (Bio-Tek
Instruments, Winooski, VT, USA) as previously described
(Figueiredo et al., 2015). Briefly, the assay was performed in a
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30◦C preheated reaction buffer (100 mM HEPES buffer, 7.7 mM
KCl, 10 mM MgSO4, pH 7.0) with 1 mM 2-PGA and different
concentrations of purified rBmEno (2.5, 5, 10, and 20 ng/µl).
The total reaction volume was 200 µl. Continuous readings were
performed every 3 min for a total of 66 min. BSA was used as a
negative control, and reactions were performed in triplicate.
The Michaelis–Menten constant (Km) for the glycolysis
substrate 2-PGA was determined from initial reaction
measurements at concentrations ranging from 1 to 10 mM.
Reactions were initiated by the addition of purified rBmEno at
1 µg/reaction. Km values were calculated using computerized
non-linear regression analysis of the data fitted to the Michaelis–
Menten equation using Graphpad Prism 5.0 (GraphPad Software,
Inc., USA).
To determine the effects of pH and temperature on rBmEno
activation, rBmEno activity was determined using a reaction
buffer system covering a pH range of 2.0–12.0, and a temperature
range of 4–90◦C. Reactions were initiated by the addition of
rBmEno (1 µg/reaction) diluted in the corresponding buffer.
Continuous readings were carried out every 3 min for 66 min,
and reactions were performed in triplicate.
Plasminogen-binding Assay
Recombinant BmEno binding to plasminogen (PLG) was assayed
by ELISA as previously described (Nogueira et al., 2012). In
brief, each well of a 96-well plate was coated overnight at 4◦C
with 4 µg/well human PLG diluted in 100 µl PBS. Non-specific
binding sites were blocked with 2% BSA in PBS for 2 h at 37◦C.
After three washes with PBST containing 0.05% (V/V) Tween
20, wells were incubated with 4 µg/well rBmEno for 2 h at
37◦C; to analyze the role of lysine residues in enolase and PLG
binding activity, 4µg/well of rBmEno were added in the presence
or absence of 0–100 mM ε-aminocaproic acid (ε-ACA, lysine
analog). After three washes, wells were incubated with polyclonal
mouse anti-rBmEno serum (1:200 dilution) for 1 h at 37◦C.
After another three washes, all wells were then incubated with
goat AP-conjugated anti-mouse IgG (1:10,000 dilution) for 1 h at
37◦C. Finally, tetramethylbenzidine substrate (TMB) was added,
and reactions were stopped by the addition of 100 µl/well of
2 N H2SO4. Absorbance was read at 450 nm using a Bio-Tek
plate reader (Bio-Tek Instruments, Winooski, VT, USA). BSA
was used as a negative control, and each assay was performed in
triplicate.
Plasminogen Activation Assay
The assay was performed in 96-well plates as previously described
(Floden et al., 2011). Briefly, each well was coated overnight
with 4 µg rBmEno in 100 µl PBS at 4◦C. After being blocked
and washed as above, 4 µg/well of human PLG was added and
incubated for 2 h at 37◦C. Following three washes, 4 ng/well
of human urokinase plasminogen activator (uPA) was added,
and then the plasmin-specific substrate D-valyl-leucyl-lysine-p-
nitroanilide dihydrochloride was added at a final concentration
of 0.3 mM in PBS. Plates were incubated overnight at 37◦C, and
absorbance was read at 405 nm using a Bio-Tek plate reader. BSA
was used as a negative control, and the assay was performed in
triplicate.
Active Immunization and Infection
Analysis
Female Balb/c mice (4–6 weeks old) were immunized with
adjuvant containing purified rBmEno protein (20 µg/mouse)
as described above, and control group mice were vaccinated
with PBS in adjuvant. Two weeks after the third boost, mice
were intraperitoneally inoculated with B. microti as described
above. Blood smears were performed every 2 days to detect
the percentage of infected RBCs by visual examination and
counting using a microscope. Mice were sacrificed 8 days after
infection. Blood samples were collected and genomic DNA was
isolated with the QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany). B. microti burden in mouse blood was evaluated via
real time quantitative RT-PCR (qRT-PCR) with the isolated DNA.
Real Time Quantitative PCR
qPCR was performed using the SYBR R© Premix Ex Taq Kit
(Takara, Dalian, China) and run on the Roche LightCycler R©
480 System following manufacturer’s instructions. B. microti was
quantified using primers targeting the small-subunit rRNA gene
and qPCR results were analyzed followed as previously described
(Bloch et al., 2013). qPCRs were performed in triplicate.
Statistical Analysis
Statistical analysis of enzyme activity, plasminogen binding, and
activation of rBmEno was performed using one-way analysis
of variance (ANOVA) and Tukey’s multiple comparison tests;
statistical analysis of qPCR was performed using two-tailed
Student’s t-tests. The values were presented as mean ± standard
deviation (SD) and considered significant at p < 0.05, data
analysis was performed with Graphpad Prism 5.0.
RESULTS
Babesia microti Enolase
An online search for B. microti genomic sequences identified
one full-length cDNA (accession number: XM_012794345)
comprising 1317 nucleotides encoding a 438 amino acid protein.
This protein was predicted to be a soluble 47.5 kDa polypeptide
with a pI of 5.98, displaying an enolase signature motif spanning
residues 349-362 (L349-S362). With subsequent protein sequence
analysis, the 2-PGA binding residues of BmEno, specifically
Ala40, His165, Gln173, Lys352, His380, Arg381, Ser382, and Lys403
were conserved, and both Glu174 and Glu217 shared a proton
during dehydration. In addition, Asp252, Glu300, and Asp327 were
found to interact with an Mg2+ ion, and Ser41 bound the second
Mg2+. Three catalytic loops of BmEno were predicted, loop1
(V36∼R57), loop2 (H165∼Q173), and loop3 (F258∼T279). BmEno
includes pentapeptide (E103W104G105F106S107) and dipeptide
insertions (V263K264), which are commonly known as plant-
like insertions. Two predicted plasminogen-binding motifs were
identified at F258∼N267 and S273∼K278, suggesting that BmEno
could bind plasminogen (Figure 1). The protein sequence also
carried phosphorylation and N-glycosylation sites, but no trans-
membrane domains or signal peptides.
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FIGURE 1 | Babesia microti enolase (BmEno) bioinformatics analysis. Comparison of enolase amino acid sequences from Babesia microti (XP_012649799),
Plasmodium falciparum (AAA18634), Theileria parva (XP_764336), Toxoplasma gondii (3OTR_A), Homo sapiens (CAA36216), and Streptococcus cerevisiae
(AOG56016) was performed with the ClustalX program. Residues interacting with 2-phospho-D- glycerate (2-PGA), residues involved in dehydration steps, and
residues interacting with Mg2+ are marked by stars, circles, and rectangles, respectively. Catalytic loops and insertions are boxed. Plasminogen (PLG) binding sites
are indicated with horizontal green lines.
FIGURE 2 | Recombinant BmEno (rBmEno) expression, purification, and antigenic characterization. (A) Sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) analysis of rBmEno expression and purification followed by Coomassie blue staining. M: prestained protein ladder, Lane 1: total cellular
proteins of pGEX-4T-2-BmEno BL21 (DE3) cells, Lane 2: supernatant of pGEX-4T-2-BmEno BL21 (DE3) cell lysate, Lane 3: sediment of pGEX-4T-2-BmEno BL21
(DE3) cell lysate, Lane 4: GST-tagged purified recombinant BmEno protein, Lane 5: purified recombinant BmEno protein. (B) Anti-B. microti serum recognized
purified recombinant BmEno. M: prestained protein ladder, Lane 1: purified GST-tagged rBmEno proteins were immunoblotted with mouse polyclonal anti-B. microti
serum, Lane 2: purified GST-tagged rBmEno proteins were immunoblotted with normal mouse serum. (C) Anti-rBmEno serum recognized native BmEno. M:
prestained protein ladder, Lane 1: B. microti-infected red blood cell (RBC) lysates were immunoprecipitated with anti-rBmEno antibody, Lane 2: normal RBC lysates
were unable to be immunoprecipitated with anti-rBmEno antibody.
rBmEno Expression, Purification, and
Antigenic Characterization
Full-length enolase cDNA was amplified from the ATCC R©
PRA-99TM B. microti strain using specific primers, and then
cloned in frame into the pGEX-4T-2 plasmid with a GST-tag
domain as described in the “Materials and Methods.” rBmEno
expression was induced in BL21 (DE3) E. coli with IPTG, and
bacterial extracts were assessed by SDS–PAGE with Coomassie
blue staining. Induced GST-tagged rBmEno protein migrated
at approximately 73 kDa, with greater amounts observed in
the supernatant than the sediment, whereas purified rBmEno
produced a single 47.5 kDa band (Figure 2A).
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FIGURE 3 | Immunofluorescent localization of BmEno in intraerythrocytic B. microti. Anti-rBmEno antibody reacted with native BmEno both in the
cytoplasm and on the surface of B. microti. Bright field images show an RBC infected with two B. microti parasites (white arrows). Under fluorescent imaging, nuclei
are stained blue with 6-diamidino-2-phenylindole (DAPI), and BmEno is stained green, indicating reaction with FITC-conjugated anti-mouse IgG anti-rBmEno
antibody. Scale bar represents 1 µm.
To analyze whether anti-B. microti serum recognized
purified recombinant BmEno, purified GST-tagged rBmEno was
incubated with the mouse anti-B. microti serum. A strong
band of approximately 73 kDa was observed in ECL-
Western blot analysis (Figure 2B). Moreover, to determine
whether anti-rBmEno antibody recognizes native BmEno,
immunoprecipitation was performed, and native BmEno was
immunoprecipitated with anti-rBmEno antibody (Figure 2C).
Immunofluorescent Localization of
BmEno in Intraerythrocytic B. microti
The localization of BmEno in intraerythrocytic B. microti
parasites was determined by immunofluorescence analysis using
a mouse anti-rBmEno antibody. Following incubation with
the anti-rBmEno antibody, intraerythrocytic parasites were
counterstained with an FITC-conjugated anti-mouse IgG and
nuclei were stained with DAPI. In Figure 3, parasitic nuclei
stained blue with DAPI and specific green anti-rBmEno antibody
reactivity was also observed. BmEno appeared to localize both
in the cytoplasm and on the surface of B. microti (based on the
observed parasite shapes).
Characterization of rBmEno Enzymatic
Activity
The classical enzymatic activity of purified rBmEno was tested
via its ability to convert 2-PGA to PEP. The catalytic activity
of rBmEno increased with increasing concentrations from 2.5
to 20 ng/µl (Figure 4A). The kinetics of the conversion
reaction revealed an 8.849 mM Michaelis constant (Km) and a
maximum velocity (Vmax) of 2.907 µmol/L/min (Figure 4B).
rBmEno enzyme activity was measured over a range of pH
values, and the enzyme’s optimal pH was determined to fall
within a neutral range, with maximal activity at pH 7.0
(Figure 4C). rBmEno enzyme activity was also assessed at varying
temperatures and was found to have maximal activity at 37◦C
(Figure 4D).
rBmEno Binds to Human Plasminogen
and Enhances Its Activation
To investigate rBmEno’s ability to bind human PLG, microtiter
plates were coated with human PLG and BSA (negative
control), and ELISA binding assays were performed. rBmEno
was found to bind human PLG compared to BSA (p < 0.0001)
(Figure 5A). To identify whether lysine residues play a role
in enolase and PLG binding, the lysine analog ε-ACA was
used as a binding competitor. ε-ACA significantly reduced
the interaction between rBmEno and PLG (p < 0.0001)
(Figure 5B). Enolase has been reported to enhance plasminogen
to plasmin activation, thus to determine whether rBmEno also
has this ability, microtiter plates were coated with rBmEno,
blocked, incubated with PLG and uPA, and proteolytic activity
measured using a plasmin-specific chromogenic substrate.
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FIGURE 4 | Recombinant BmEno enzymatic activity and influencing factors. (A) Effect of different rBmEno concentrations on enzymatic activity. (B) Km and
Vmax for rBmEno were determined as 8.849 mM and 2.907 µmol/L/min, respectively, based on the Lineweaver–Burk plot (double-reciprocal plot). (C) rBmEno
activity in a buffer system covering a 2–12 pH range, enzymatic activity was maximal at pH 7.0. (D) rBmEno activity in a buffer system covering the temperature
range 4–90◦C, enzymatic activity was maximal at 37◦C. Relative activity of rBmEno was measured by OD240 absorbance. All data shown represent the mean ± SD
from three independent experiments. Significant differences as compared to other conditions are denoted by ∗ for p < 0.05, and ∗∗ for p < 0.001.
rBmEno dramatically enhanced plasmin activation in the
presence of uPA compared to the negative control BSA
(p< 0.0001) (Figure 5C).
Active rBmEno Immunization of Mice
Evokes Partial Protective Immunity
We have demonstrated that BmEno is expressed at the surface of
B. microti parasites, thus we hypothesized that immunization of
mice with rBmEno could elicit protective immunity and influence
any subsequent B. microti infection. Therefore Balb/c mice (four
animals/group) were immunized with purified rBmEno, while
control mice were injected with PBS mixed with similar volume
of adjuvant. Two weeks after the final immunization, mice
were intraperitoneally inoculated with B. microti. Blood smears
performed every 2 days after infection demonstrated that the
percentage of B. microti-infected RBCs from protein-immunized
mice was significantly lower than that from control mice after
4 days following parasite (p < 0.001) (Figure 6A). Additionally,
qPCR showed that the parasitic blood burden was significantly
decreased 1.5-fold in immunized mice after 8 days following
parasite infection, than in controls (p< 0.05) (Figure 6B).
DISCUSSION
Enolase is an essential glycolytic enzyme in intracellular glucose
metabolism, but is also referred to as a multifunctional protein, as
it is also expressed on the pathogen surfaces (Ghosh and Jacobs-
Lorena, 2011). In this study, we characterized a 47.5 kDa protein
containing signature enolase motif residues, derived from the
apicomplexan parasite B. microti. In order to evaluate the BmEno
functional motif, bioinformatics sequence alignment analysis was
performed with freely available sequence data. Both the 2-PGA
binding residues and catalytic loops of BmEno were conserved
when compared to Streptococcus cerevisiae yeast enolase and
Toxoplasma gondii enolase (Zhang et al., 1997; Ruan et al., 2015)
(Figure 1). The plasminogen-binding motif (FYDKERKVYD),
first analyzed in Streptococcus pneumoniae surface enolase, was
found to be required for proteolytic activity in the infected
host (Bergmann et al., 2003). This motif is presented as
FYQKDVKMYN in BmEno (Figure 1). The Plasmodium enolase
contains an alternate plasminogen-binding motif (DKSLVK)
(Ghosh et al., 2011), and the similar sequence SSPDIK can
be identified in BmEno (Figure 1). BmEno also contains the
plant-like pentapeptide (EWGFS) and dipeptide (VK) insertions
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FIGURE 5 | Recombinant BmEno binds to human PLG and enhances its activation. (A) rBmEno binding to immobilized human PLG protein was analyzed via
enzyme-linked immunosorbent assay (ELISA), BSA was used as a negative control for non-specific binding. rBmEno binding activity was measured by absorbance at
OD450. (B) rBmEno binding to immobilized PLG protein was analyzed by ELISA. rBmEno was added to PLG-coated wells in the presence or absence of 0–100 mM
ε-aminocaproic acid (ε-ACA) rBmEno binding activity was measured by absorbance at OD450. (C) rBmEno-coated wells of microtiter plates were incubated with
PLG, uPA, and/or a plasmin-specific chromogenic substrate, BSA was used as a negative control. Proteolytic activity was measured by absorbance at OD405. All
data shown represent the mean ± SD from three independent experiments. Significant differences compared to control are denoted by ∗∗∗ for p < 0.0001.
(Dzierszinski et al., 2001). Deleting the EWGWS pentapeptide
insertion from the P. falciparum enolase results in reduced
kcat/Km and dissociation into monomers (Vora et al., 2009).
And finally, neither trans-membrane domains nor signal peptides
were predicted in BmEno, thus confirming identification as an
enolase-like structure (Pancholi, 2001; Diaz-Ramos et al., 2012).
Taken together, BmEno contains catalytic residues, catalytic
flexible loops, several insertions, and plasminogen-binding sites.
In order to biochemically characterize BmEno, we prepared
recombinant BmEno protein in E. coli BL21 (DE3), and
immunized Balb/c mice with purified rBmEno to generate
anti-rBmEno serum. rBmEno was highly expressed as an
IPTG-inducible soluble protein in BL21 (DE3), anti-rBmEno
mouse serum recognized native BmEno, and mice were able
to produce antibodies to BmEno during the natural course of
infection (Figure 2). Taken together, these results indicate that
enolase could be used as a potential diagnostic biomarker for
babesiosis, as it has already been used for the diagnosis of
numerous infectious diseases such as malaria or leishmaniasis
(Sato et al., 2000; Duarte et al., 2015). However, its applicability
in diagnostic tests should be fully investigated. Until recently,
enolase was only recognized as an important cytosolic protein,
however, new evidence confirms its presence on the surface
of a variety of organisms (Pal-Bhowmick et al., 2007; Floden
et al., 2011; Figueiredo et al., 2015). In the current study,
our immunofluorescence results also confirmed that B. microti
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FIGURE 6 | Active immunization of mice with rBmEno evokes partial protective immunity. (A) The percentage of infected RBCs was determined by
counting the number of infected RBCs versus the total number of RBCs using blood smear with Giemsa staining, a minimum of 600 RBCs were counted and an
RBC infected with multiple parasites was counted as a single infected cell. (B) The parasitic burden in mouse blood was evaluated with qPCR to detect the
B. microti small-subunit rRNA gene. All data shown represent the mean ± SD from four independent mice. Significant differences compared to control are denoted
by ∗ for p < 0.05, and ∗∗ for p < 0.001.
enolase is expressed in the cytosol and additionally on the
organism surface (Figure 3).
As a cytoplasmic protein, enolase plays a pivotal role in glucose
metabolism (Pancholi, 2001; Diaz-Ramos et al., 2012). Purified
rBmEno was able to catalyze the conversion of 2-PGA to PEP in a
reaction buffer with 10 mM Mg2+ at 30◦C and pH 7.0. However,
the enzymatic activity was influenced by both temperature and
pH (Figure 4). Furthermore, rBmEno showed high Km and Vmax
values compared to other pathogenic organisms during 2-PGA
to PEP conversion (Bao et al., 2014; Figueiredo et al., 2015).
This may be due to the fact that the parasite produces its energy
mainly through anaerobic glycolysis during erythrocytic stages
(Cornillot et al., 2012).
As a surface-exposed protein, the plasminogen receptor
enolase can promote the conversion of the zymogen plasminogen
to its active form, plasmin, in the presence of plasminogen
activator (Floden et al., 2011; Ghosh et al., 2011; Nogueira
et al., 2012; Toledo et al., 2012; Figueiredo et al., 2015). In
other protozoan parasites such as P. falciparum, Leishmania
mexicana, and Trichomonas vaginalis, enolase has been shown
to bind to plasminogen (Vanegas et al., 2007; Mundodi
et al., 2008; Bhowmick et al., 2009). Subsequently, our ELISA
experiment to examine BmEno/plasminogen binding confirmed
that rBmEno was also able to bind to human plasminogen
(Figure 5A). It’s well known that lysine residues play an
important role in the interaction of plasminogen receptors
with their ligand (Ghosh and Jacobs-Lorena, 2011), and that
competitive binding assays with lysine analogs such as ε-ACA
have demonstrated that most bacterial and parasitic enolases
do bind plasminogen through their lysine residues (Miles
et al., 2005; Figuera et al., 2013; Miles and Parmer, 2013).
Furthermore, in S. pneumoniae enolase, lysine residues have been
identified in the “FYDKERKVYD” motif (Bergmann et al., 2003),
similar to the “FYQKDVKMYN” BmEno plasminogen-binding
domain predicted by bioinformatics analysis. Our competitive
binding experiments with ε-ACA significantly inhibited rBmEno
plasminogen binding (Figure 5B), thereby confirming that lysine
residues play an essential role in BmEno/plasminogen binding.
The active form of the mammalian liver enzyme plasminogen
is plasmin, a serine protease that plays a key role in degrading
the target host cell extracellular matrix during infection with
pathogenic organisms (Lahteenmaki et al., 2005; Gonzalez-
Miguel et al., 2016). Plasminogen activation also requires
tissue/uPA, and it has also been reported that surface expressed
enolase can enhance the activation process (Floden et al., 2011;
Ghosh et al., 2011; Nogueira et al., 2012; Toledo et al., 2012;
Figueiredo et al., 2015). We showed that rBmEno dramatically
enhanced plasmin activation in the presence of urokinase
plasminogen activator (Figure 5C). Interestingly, in vitro studies
have shown that P. falciparum enolase antibody was able to
block merozoite invasion of RBCs (Pal-Bhowmick et al., 2007)
suggesting that enolase plays an unknown role in the RBC
invasion process. Here, we hypothesized that apicomplexan
parasites utilize surface-expressed enolase to promote plasmin
generation, which then degrades RBC membrane sections,
enabling rapid RBC invasion. Moreover, apicomplexan parasites
could also utilize the ability of surface-exposed enolase to bind
plasminogen to invade vector gut epithelium (Ghosh et al., 2011).
Moreover, enolase may also be an important candidate antigen
for vaccines against pathogen infection (Pal-Bhowmick et al.,
2007; Zhang et al., 2015, 2016; Mahana et al., 2016; Membrebe
et al., 2016). It has been reported that mice immunized with
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r-Pfen antigen were strongly protected against infection
when challenged with mouse malarial parasite Plasmodium
yoelii (Pal-Bhowmick et al., 2007), therefore we also tested the
protective properties of B. microti enolase. Our immunization
experiments demonstrated that enolase antibodies slightly but
significantly reduced both parasitemia and parasite levels in
murine blood (Figure 6). Such variable protective properties may
be due to varying quality of immunized protein. Furthermore,
each mouse was only immunized with 20 µg rBmEno whereas
100 µg protein was used to immunize each mouse in the r-Pfen
protection test. Further research is now required in order to
evaluate BmEno’s potential as a candidate vaccine to control
babesiosis infection.
CONCLUSION
Our results demonstrate that the BmEno gene encodes a
classical 47.5 kDa enolase enzyme, which possesses a highly
conserved active site and plasminogen-binding domains. BmEno
is internally expressed and likely plays a role in glycolysis,
however, it also catalyzes the reversible dehydration of 2-PGA to
yield PEP. Furthermore, BmEno is also expressed at the external
surface parasite surface, where it can bind to and enhance the
activation of plasminogen. We have also confirmed that lysine
residues play an important role in BmEno and plasminogen
interaction. Moreover, BmEno could evoke a partial protective
response against B. microti infection, thus BmEno’s potential
as a candidate vaccine to control babesiosis infection should
be evaluated in the future. In summary, this detailed first
characterization of Babesia enolase improves our understanding
of host cell invasion mechanisms by this intraerythrocytic
pathogenic parasite.
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